
USD
+$0.00
(+0.00%
)At Close (As of Dec 12, 2025)
$10.58B
Market Cap
304.14
P/E Ratio
0.07
EPS
$23.70
52 Week High
$8.02
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $1.9B |
| Total Revenue | $4.4B |
| Cost Of Revenue | $2.5B |
| Costof Goods And Services Sold | $2.5B |
| Operating Income | $251M |
| Selling General And Administrative | $1.1B |
| Research And Development | $344M |
| Operating Expenses | $1.7B |
| Investment Income Net | - |
| Net Interest Income | -$235M |
| Interest Income | - |
| Interest Expense | $339M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $662M |
| Income Before Tax | $488M |
| Income Tax Expense | $150M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $338M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $827M |
| Ebitda | $1.5B |
| Net Income | $338M |
| Field | Value (USD) |
|---|---|
| Total Assets | $13B |
| Total Current Assets | $3.2B |
| Cash And Cash Equivalents At Carrying Value | $468M |
| Cash And Short Term Investments | $468M |
| Inventory | $1.6B |
| Current Net Receivables | $886M |
| Total Non Current Assets | $9.4B |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $3.7B |
| Intangible Assets Excluding Goodwill | $3.7B |
| Goodwill | $4.4B |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $287M |
| Other Non Current Assets | - |
| Total Liabilities | $6.5B |
| Total Current Liabilities | $1.3B |
| Current Accounts Payable | $296M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $44M |
| Total Non Current Liabilities | $5.2B |
| Capital Lease Obligations | - |
| Long Term Debt | $4.3B |
| Current Long Term Debt | $44M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $4.3B |
| Other Current Liabilities | $975M |
| Other Non Current Liabilities | $302M |
| Total Shareholder Equity | $6.1B |
| Treasury Stock | - |
| Retained Earnings | -$2B |
| Common Stock | - |
| Common Stock Shares Outstanding | $497M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $1.9B |
| Total Revenue | $4.4B |
| Cost Of Revenue | $2.5B |
| Costof Goods And Services Sold | $2.5B |
| Operating Income | $251M |
| Selling General And Administrative | $1.1B |
| Research And Development | $344M |
| Operating Expenses | $1.7B |
| Investment Income Net | - |
| Net Interest Income | -$235M |
| Interest Income | - |
| Interest Expense | $339M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $662M |
| Income Before Tax | $488M |
| Income Tax Expense | $150M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $338M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $827M |
| Ebitda | $1.5B |
| Net Income | $338M |
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Elanco Animal Health Incorporated (ELAN) is a premier global leader in the animal health sector, committed to enhancing the health and productivity of both companion animals and livestock. Headquartered in Greenfield, Indiana, Elanco offers an extensive portfolio of scientifically advanced products tailored to meet the evolving needs of veterinarians and producers worldwide. With a strong emphasis on research and sustainable practices, the company is strategically positioned to meet the increasing global demand for innovative animal health solutions. Elanco’s proactive investments in innovation aim to foster significant growth while contributing to animal welfare and improving food supply chain efficiencies.